This series of Allergy Relief Treatments is an intended to restore proper function of following issues associated with Autism.
When the body creates antibodies or autoantibodies it is exhibiting an allergic response. The approach is to clear the allergy, just as though it was a food or environmental allergy. Only in this case it’s a biological allergy.
The following is a series of Allergy Relief Treatments I performed on two boys who were unable to speak. One of them is now speaking normally and the other has improved by 80%. The good news here is that I can teach parents how to do each of these Allergy Relief Treatments on their own autistic children in the privacy and comfort of their own homes. Please contact me at 425-776-8657 to learn more.
- Serotonin Level (blood)
- Serotonin Receptor Antibodies
- Serotonin Antibodies
- Somatostatin Antibodies
- Vasoactive Intestinal Peptide
- Recent data link vasoactive intestinal peptide malfunction with developmental delays and cognitive deficits. Blockage of vasoactive intestinal peptide during rodent development results in growth and developmental delays, neuronal dystrophy, and, in adults, cognitive dysfunction. Also, vasoactive intestinal peptide is elevated in the blood of newborn children with autism.
- In the current experiments, vasoactive intestinal peptide binding sites were significantly increased in several brain areas of the segmental trisomy mouse, including the olfactory bulb, hippocampus, cortex, caudate/putamen, and cerebellum, compared with wild-type littermates.
- Prodynorphin + Dynorphin
- Dipeptidylpeptidase IV (CD26)
- Dipeptidyl peptidase IV (DPP IV) (CD26) plays a critical rolein the modulation and expression of autoimmune and inflammatory dipeptidyl peptidase IV diseases. It is believed that (DPPIV/CD26) is defective in children with autism.
- Children with autism and patients with autoimmune disease developed anti-dipeptidylpeptidase I (DPPI), anti-dipeptidylpeptidase IV (DPP IV [or CD26]) and anti-aminopeptidaseN (CD13) autoantibodies. A significant percentage of autoimmune and autistic sera were associated with elevated immunoglobulinG (IgG), IgM, or IgA antibodies against three peptidases, gliadin,and HSP-60.
- Complex Dipeptidylpeptidave IV (CD26)
